Education and Assistance for Normal Pressure Hydrocephalus
(NPH Trial)
Trial Summary
What is the purpose of this trial?
The study aims to estimate Normal Pressure Hydrocephalus (NPH) prevalence and evaluate health equity gaps in Baltimore and Maryland based on zip codes and race, with a focus on the Black community. Interventions will include educational elements about NPH and three layers targeting patients, Primary Care Providers, and community health workers to enhance care access. Short-term outcomes will measure referrals to specialists, while long-term outcomes will assess healthcare utilization. The study aims to identify and reduce racial disparities in NPH care access, informing intervention strategies for NPH and other surgical areas.
Research Team
Hossein Zare, PhD
Principal Investigator
Johns Hopkins Bloomberg School of Public Health
Eligibility Criteria
This trial is for individuals in Maryland, particularly from the Black community, who may be affected by Normal Pressure Hydrocephalus (NPH). It aims to address health disparities and improve care access. Participants should be interested in learning about NPH or are healthcare providers looking to enhance their understanding of NPH management.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- NPH Training (Education)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins Bloomberg School of Public Health
Lead Sponsor
Dr. Joshua M. Sharfstein
Johns Hopkins Bloomberg School of Public Health
Chief Medical Officer since 2015
MD from Johns Hopkins University
Dr. Ellen J. MacKenzie
Johns Hopkins Bloomberg School of Public Health
Chief Executive Officer since 2017
MD from Johns Hopkins University